Broadwood Partners, L.P. Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

Broadwood Partners, L.P. is Director of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 41.7 Million shares of LCTX, which is worth approximately $20.8 Million. The most recent transaction as insider was on Feb 06, 2024, when has been sold 6,730,770 shares (Common Shares) at a price of $1.04 per share, resulting in proceeds of $7,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.7M

0% 3M change

19.27% 12M change

Total Value Held $20.8 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2024	BUY Open market or private purchase	$7,000,000 $1.04 p/Share	6,730,770 Added 13.91%	41,666,255 Common Shares
Mar 25 2022	BUY Open market or private purchase	$676,800 $1.44 p/Share	470,000 Added 1.33%	34,935,485 Common Shares
Mar 24 2022	BUY Open market or private purchase	$284,000 $1.42 p/Share	200,000 Added 0.58%	34,465,485 Common Shares
Mar 23 2022	BUY Open market or private purchase	$356,345 $1.37 p/Share	260,106 Added 0.75%	34,265,485 Common Shares
Aug 15 2019	BUY Open market or private purchase	$12,752 $0.97 p/Share	13,146 Added 0.04%	34,005,379 Common Shares
Aug 14 2019	BUY Open market or private purchase	$1,379 $0.98 p/Share	1,407 Added 0.0%	33,992,233 Common Shares
Aug 13 2019	BUY Open market or private purchase	$9,900 $0.99 p/Share	10,000 Added 0.03%	33,990,826 Common Shares
Apr 16 2019	BUY Other acquisition or disposition	$332,422 $1.32 p/Share	251,835 Added 0.74%	33,980,826 Common Shares
Mar 08 2019	BUY Other acquisition or disposition	-	3,757,430 Added 10.02%	33,728,991 Common Shares
Oct 13 2017	BUY Open market or private purchase	$6,999,998 $2.6 p/Share	2,692,307 Added 8.24%	29,971,561 Common Stock
Aug 22 2017	BUY Open market or private purchase	$26,000 $2.6 p/Share	10,000 Added 0.04%	27,279,254 Common Stock

Also insider at

STAA

STAAR SURGICAL CO Healthcare

> 10% Shareholder

OCX

Oncocyte Corp Healthcare

> 10% Shareholder

CMRO

COMARCO INC

> 10% Shareholder

BPL